Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
ARGX.BR - argenx SE
argenx SE To Acquire Forte Biosciences
Jul 27, 2026 / 12:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
The press release can be found on our website along with a slide presentation that you can follow as you listen to the call.
I'm joined today by Karen Massey, Chief Executive Officer, Ariane Lemon, Vice President of Corporate Development and Strategy, and Peter Ulrich, Chief Scientific Officer.
Karl Gubitz, our Chief Financial Officer, will be available during the Q&A.
Before we begin on slide 2, I'd like to remind you that forward-looking statements may be presented during this call.
These may include statements about our future expectations, clinical developments, regulatory timelines, the potential success of our product candidates, financial projections, upcoming milestones, and the anticipated benefits
Trustpilot
